The role of artificial intelligence in postoperative clinical decision-making for pancreatic cancer: a pilot study - Takeaways - MDSpire

The role of artificial intelligence in postoperative clinical decision-making for pancreatic cancer: a pilot study

  • By

  • Samet Yigman

  • Ahmet Onur Demirel

  • Ibrahim Halil Ozata

  • Burak Çelik

  • Safa Toprak

  • Salih Karahan

  • Volkan Adsay

  • Orhan Bilge

  • Gürkan Tellioğlu

  • June 1, 2026

  • 0 min

Share

  • 1

    The study compares multidisciplinary tumor board (MDT) decision-making with an AI-assisted model for postoperative pancreatic cancer management.

  • 2

    An AI model was developed using clinical data from 67 patients discussed in MDTs, aiming to support postoperative treatment decisions.

  • 3

    The concordance rate between AI recommendations and MDT decisions was 80%, indicating moderate agreement beyond chance.

  • 4

    Discrepancies between AI and MDT decisions highlight the importance of expert clinical judgment in complex cases.

  • 5

    AI-based models may reduce workload and time in clinical decision-making but should complement, not replace, expert evaluations.

Original Source(s)

The role of artificial intelligence in postoperative clinical decision-making for pancreatic cancer: a pilot study

  • by Samet Yigman, Ahmet Onur Demirel, Ibrahim Halil Ozata, Burak Çelik, Safa Toprak, Salih Karahan, Volkan Adsay, Orhan Bilge, Gürkan Tellioğlu

  • June 1, 2026

Related Content

ISG15 deficiency in hepatic stellate cells promotes TGFβ2-induced liver fibrosis by counteracting CREB1 ISGylation

Sustained complete response to TMEp-CI-M platform in refractory small-cell lung cancer with brainstem metastasis: a case report with over 20 months of disease-free survival

Effects of Arylsulfatase B and Pembrolizumab in combination on progression of metastatic melanoma in the B16F10 syngeneic mouse model